World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
40992
World Ranking
12936
National Ranking
6614

Overview

Catherine Schairer is affiliated with the National Institutes of Health in the United States and has contributed extensively to research in medicine, with a particular focus on oncology and molecular biology. Their work spans multiple subfields, including cancer research, genetics, reproductive medicine, and molecular biology. The main topics of their research cover areas such as cancer risks and factors, epigenetics and DNA methylation, ovarian cancer diagnosis and treatment, reproductive biology and fertility, endometrial and cervical cancer treatments, cholangiocarcinoma and gallbladder cancer studies, and viral-associated cancers and disorders.

The scientist has published in several respected journals, most frequently in Breast Cancer Research and Treatment and UNC Libraries. Other venues include Cancer Research, British Journal of Cancer, and Sensors. Their recent notable papers include:

  • "The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)", 2020, Cancer Research
  • "Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank", 2020, British Journal of Cancer
  • "Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study", 2020, Breast Cancer Research and Treatment
  • "Imaging Modalities in Inflammatory Breast Cancer (IBC) Diagnosis: A Computer-Aided Diagnosis System Using Bilateral Mammography Images", 2022, Sensors
  • "Risk factors for inflammatory and non-inflammatory breast cancer in North Africa", 2020, Breast Cancer Research and Treatment

Catherine Schairer has collaborated frequently with several coauthors, including Julie E. Buring, Thomas E. Rohan, Anne Zeleniuch-Jacquotte, Ruth M. Pfeiffer, and Victoria A. Kirsh. Each of these collaborations has appeared multiple times in the body of work, reflecting ongoing research partnerships.

The scope of research covered includes 11 publications in medicine overall and 8 specifically in biochemistry, genetics, and molecular biology. The integration of epidemiological and molecular approaches is evident in their studies, especially those dealing with cancer risk factors and diagnostics.

This profile highlights the interdisciplinary nature of Catherine Schairer's research, merging clinical and molecular perspectives to contribute to the understanding of cancer and reproductive health.

Best Publications

  • Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually

    Mitchell H. Gail;Louise A. Brinton;David P. Byar;Donald K. Corle

  • Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

    E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff

  • Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies

    E. E. Calle;C. W. Heath;H. L. Miracle-McMahill;R. J. Coates

  • ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATA

    Paolo Bruzzi;Sylvan B. Green;David P. Byar;Louise A. Brinton

  • Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

    Catherine Schairer;Jay Lubin;Rebecca Troisi;Susan Sturgeon

  • Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults

    Steven C. Moore;I-Min Lee;Elisabete Weiderpass;Peter T. Campbell

  • Alcohol, tobacco and breast cancer - Collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

    N Hamajima;K Hirose;K Tajima;T Rohan

  • Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status

    Celia Byrne;Catherine Schairer;John Wolfe;Navin Parekh

  • Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

  • The Risk of Breast Cancer after Estrogen and Estrogen-Progestin Replacement

    LElF Bergkvist;Hans-Olgy Adami;Ingemar Persson;Robert Hoover

  • Menopausal hormone replacement therapy and risk of ovarian Cancer

    James V. Lacey;Pamela J. Mink;Jay H. Lubin;Mark E. Sherman

  • Type I and II Endometrial Cancers: Have They Different Risk Factors?

    Veronica Wendy Setiawan;Hannah P. Yang;Malcolm C. Pike;Malcolm C. Pike;Susan E. McCann;Susan E. McCann

  • A Prospective Study of Diet Quality and Mortality in Women

    A K Kant;A S Schatzkin;B I Graubard;C Schairer

  • Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

  • Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.

    I. Persson;H. O. Adami;L. Bergkvist;A. Lindgren

  • Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

    Nicolas Wentzensen;Elizabeth M. Poole;Britton Trabert;Emily White

  • Association between Class III Obesity (BMI of 40-59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies

    Cari M. Kitahara;Alan J. Flint;Amy Berrington de Gonzalez;Leslie Bernstein

  • Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

    Ingemar Persson;Jonathan Yuen;Leif Bergkvist;Catherine Schairer

  • Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.

    Jinbo Chen;David Pee;Rajeev Ayyagari;Barry Graubard

  • Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.

    Ingemar Persson;Elisabete Vainio Weiderpass;Leif Bergkvist;Reinhold Bergström;Reinhold Bergström

Frequent Co-Authors

Louise A. Brinton
Louise A. Brinton National Institutes of Health
Robert N. Hoover
Robert N. Hoover National Institutes of Health
Julie E. Buring
Julie E. Buring Brigham and Women's Hospital
Hans-Olov Adami
Hans-Olov Adami Karolinska Institute
Howard D. Sesso
Howard D. Sesso Harvard Medical School
I-Min Lee
I-Min Lee Harvard University
Regina G. Ziegler
Regina G. Ziegler National Institutes of Health
Susan M. Gapstur
Susan M. Gapstur American Cancer Society
Patricia Hartge
Patricia Hartge National Institutes of Health
Alicja Wolk
Alicja Wolk Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond a traditional MD, there are a variety of flexible and accessible online options. Financial aid for medical billing and coding programs makes it easier to enter this vital administrative field without a heavy upfront investment.

Aspiring nurses can take advantage of nursing school no entrance exam options, helping candidates start their education sooner and with fewer barriers to entry.

Those interested in the leadership side of healthcare can pursue an online healthcare management degree, gaining the skills needed for roles in administration, management, and policy.

Registered Nurses (RNs) looking to advance their clinical expertise have access to streamlined rn to np bridge program pathways, enabling them to become nurse practitioners faster while keeping work and study balanced.

These options underscore the diverse, accessible, and practical routes available for those passionate about making a difference in healthcare, whether through patient care, administration, or supporting roles.

Best Scientists Citing Catherine Schairer

Trending Scientists

Recently Published Articles